Perimenopause pp 271-280 | Cite as

Medical Management of Menorrhagia in Pre- and Perimenopausal Women

  • David F. Archer
Part of the Serono Symposia USA book series (SERONOSYMP)


Several studies have documented that the perimenopausal transition in terms of menstrual period intervals and duration of bleeding is similar to that which is experienced at the onset of menarche in the adolescent. That is, the interval between menstrual periods begins to lengthen and the duration of bleeding remains unchanged. Current evidence suggests that, along with the lengthening of the interval between menstrual periods, the amount of flow with each menstrual period also changes (1–3). The amount of menstrual bleeding both increases and decreases in perimenopausal women. The percentage of perimenopausal women reporting a change in menstrual flow was 51% (n = 194) of 380 women (3). An increase in the amount of menstrual flow has been positively correlated with the irregular menses that occur in perimenopausal women (2).


Obstet Gynecol Tranexamic Acid GnRH Agonist Menstrual Period Uterine Fibroid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas 1992;14:103–15.PubMedCrossRefGoogle Scholar
  2. 2.
    Metcalf MG, Donald RA, Livesey JH. Classification of menstrual cycles in pre-and perimenopausal women. J Endocrinol 1981;91:1–10.PubMedCrossRefGoogle Scholar
  3. 3.
    Burger HG, Dudley EC, Hopper JL, et al. The endocrinology of the menopause transition: a cross-sectional study of a population-based sample. J Clin Endocrinol 1995;80:3537–45.CrossRefGoogle Scholar
  4. 4.
    Van Eijkeren MA, Christiaens GCML, Sikma JJ, Haspels AA. Menorrhagia: a review. Obstet Gynecol Surv 1989;44:421–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Cohen BJB, Gibor Y. Anemia and menstrual blood loss. Obstet Gynecol Surv 1980;35:597–618.PubMedGoogle Scholar
  6. 6.
    Fraser IS, Baird DT. Blood production and ovarian secretion rates of estradiol-1703B2 and estrone in women with dysfunctional uterine bleeding. J Clin Endocrinol Metab 1974;39:564–70.PubMedCrossRefGoogle Scholar
  7. 7.
    Shaw RW. Assessment of medical treatments for menorrhagia. Br J Obstet Gynaecol 1994;101:15–18.PubMedCrossRefGoogle Scholar
  8. 8.
    Smith SK, Abel MH, Kelly RW, Baird DT. Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. Br J Obstet Gynaecol 1981;88:434–42.PubMedCrossRefGoogle Scholar
  9. 9.
    Gleeson N, Devitt M, Sheppard BL, Bonnar J. Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding. Br J Obstet Gynaecol 1993;100:768–71.PubMedCrossRefGoogle Scholar
  10. 10.
    Santoro N, Brown JR, Adel T, Skurnick JH. Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab 1996; 81:1495–501.PubMedCrossRefGoogle Scholar
  11. 11.
    Van Look PFA, Lothian H, Hunter WM, Michie EA, Baird DT. Hypothalamic-pituitary-ovarian function in perimenopausal women. Clin Endocrinol 1977;7:13–31.CrossRefGoogle Scholar
  12. 12.
    Metcalf MG, Donald RA, Livesey JH. Pituitary-ovarian function in normal women during the menopausal transition. Clin Endocrinol 1981;14:245–55.CrossRefGoogle Scholar
  13. 13.
    Critchley HOD, Abberton KM, Taylor NH, Healy DL. Endometrial sex steroid receptor expression in women with menorrhagia. Br J Obstet Gynaecol 1994; 101:428–34.PubMedCrossRefGoogle Scholar
  14. 14.
    Carlson KJ, Nichols DH, Schiff I. Indications for hysterectomy. N Engl J Med 1993;328:856–60.PubMedCrossRefGoogle Scholar
  15. 15.
    Lalonde A. Evaluation of surgical options in menorrhagia. Br J Obstet Gynaecol 1994;101:8–14.PubMedCrossRefGoogle Scholar
  16. 16.
    Donnez J, Nisolle M, Clerck F, Casanas-Roux F, Saussoy P, Gillerot S. Advanced endoscopic techniques used in dysfunctional bleeding, fibroids and endometriosis, and the role of gonadotrophin-releasing hormone agonist treatment. Br J Obstet Gynaecol 1994;101:2–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Derman SG, Rehnstrom J, Neuwirth RS. The long-term effectiveness of hysteroscopic treatment of menorrhagia and leiomyomas. Obstet Gynecol 1991;77:591–6.PubMedGoogle Scholar
  18. 18.
    Nilsson L, Rybo G. Treatment of menorrhagia. Am J Obstet Gynecol 1971; 110:713–20.PubMedGoogle Scholar
  19. 19.
    Fraser IS, McCarron G. Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia. Aust NZ J Obstet Gynecol 1991;31:66–70.CrossRefGoogle Scholar
  20. 20.
    Preston JT, Cameron IT, Adams EJ, Smith SK. Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia. Gynaecology 1993;102:401–8.Google Scholar
  21. 21.
    Cameron IT, Haining R, Lumsden M-A, Thomas VR, Smith SK. The effects of mefenamic acid and norethisterone on measured menstrual blood loss. Obstet Gynecol 1990;76:85–8.PubMedGoogle Scholar
  22. 22.
    Fraser IS. Treatment of ovulatory and anovulatory dysfunctional uterine bleeding with oral progestogens. Aust NZ J Obstet Gynecol 1990;30:353–6.CrossRefGoogle Scholar
  23. 23.
    Higham JM, Shaw RW. A comparative study of danazol, a regimen of decreasing doses of danazol, and norethindrone in the treatment of objectively proven unexplained menorrhagia. Am J Obstet Gynecol 1993;169:1134–9.PubMedGoogle Scholar
  24. 24.
    Chimbira TH, Anderson ABM, Naish C, Cope E, Turnbull AC. Reduction of menstrual blood loss by danazol in unexplained menorrhagia: lack of effect of placebo. Br J Obstet Gynaecol 1980;87:1152–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Tang GWK, Lo SST. Levonorgestrel intrauterine device in the treatment of menorrhagia in Chinese women: efficacy versus acceptability. Contraception 1995;51:231–5.PubMedCrossRefGoogle Scholar
  26. 26.
    Andersson JK, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol 1990;97:690–4.PubMedCrossRefGoogle Scholar
  27. 27.
    Milsom I, Andersson K, Andersch B, Rybo G. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. Am J Obstet Gynecol 1991; 164:879–83.PubMedGoogle Scholar
  28. 28.
    Bergquist A, Rybo G. Treatment of menorrhagia with intrauterine release of progesterone. Br J Obstet Gynaecol 1983;90:255–8.CrossRefGoogle Scholar
  29. 29.
    Hahn L, Petruson B. The influence of acetylsalicylic acid and paracetomol on menstrual blood loss in women with and without an intrauterine contraceptive device. Am J Obstet Gynecol 1979;135:393–6.PubMedGoogle Scholar
  30. 30.
    Chamberlain G, Freeman R, Price F, Kennedy A, Green D, Eve L. A comparative study of ethamsylate and mefenamic acid in dysfunctional uterine bleeding. Br J Obstet Gynaecol 1991;98:707–11.PubMedCrossRefGoogle Scholar
  31. 31.
    van Eijkeren MA, Christiaen GCML, Geuze HJ, Haspels AA, Sixma JJ. Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia. Am J Obstet Gynecol 1992;166:1419–28.PubMedGoogle Scholar
  32. 32.
    Hall P, Maclachlan N, Thorn N, Nudo MWE, Taylor CG, Garrioch DB. Control of menorrhagia by the cyclo-oxygenase inhibitors naproxen sodium and mefenamic acid. Br J Obstet Gynaecol 1987;94:554–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Cameron IT, Leask R, Kelly RW, Baird DT. The effects of danazol, mefenamic acid, norethisterone, and a progesterone-impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia. Prostaglandin 1987;34:99–110.CrossRefGoogle Scholar
  34. 34.
    Mäkäräinen L, Ylikorkala O. Primary and myoma associated menorrhagia: role of prostaglandin and effects of ibuprofen. Br J Obstet Gynaecol 1986:93:974–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Vercellini P, Crosignani PG. Goserelin (Zoladex) and the anaemic patient. Br J Obstet Gynaecol 1994;1001:33–7.Google Scholar
  36. 36.
    Petrucco OM, Fraser IS. The potential for the use of GnRH agonists for treatment of dysfunctional uterine bleeding. Br J Obstet Gynaecol 1992; 99:34–6.PubMedCrossRefGoogle Scholar
  37. 37.
    Thomas EJ, Okuda KJ, Thomas NM. The combination of a depo-gonado-trophin releasing hormone agonist and cyclical hormone replacement therapy for dysfunctional uterine bleeding. Br J Obstet Gynaecol 1991;98:1155–9.PubMedCrossRefGoogle Scholar
  38. 38.
    Carlson KJ, Miller BA, Fowler FJ. The Maine women’s health study: II. Outcome of nonsurgical management of leiomyomas, abnormal bleeding, and chronic pelvic pain. Obstet Gynecol 1994;83:566–72.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1997

Authors and Affiliations

  • David F. Archer

There are no affiliations available

Personalised recommendations